Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Bal (PPP1) > Clinical Case Studies Week 5 (Depression, Psychosis + Schiz, Dementia) > Flashcards

Clinical Case Studies Week 5 (Depression, Psychosis + Schiz, Dementia) Flashcards

1
Q

What does the psychological treatment of depression consist of?

A

Structured problem-solving strategies

Stress management strategies

CBT

Interpersonal psychotherapy (IPT)

Short-term dynamic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which SSRI/SNRI will have withdrawal effects? Why? What are these withdrawal effects?

A

Fluvoxamine, paroxetine, and venlafaxine as these have short half lives.

Withdrawal effects for SSRIs and SNRIs: Dizziness, nausea, paraesthesia, anxiety, agitation, tremor, sweating, confusion, electric shock-like sensations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When do SSRI doses need adjustment?

A

Doses usually need adjustment in hepatic impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What differentiates escitalopram from other SSRIs?

A

Escitalopram - causes less sedation, sexual dysfunction and no agitation or weight gain due to high receptor selectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the following drug interactions and precuations for SSRI

A) Platelet aggregation

B) Hyponatraemia risk

C) QT interval prolongation/arrhythmia risk

A

A)

  • Caution with other drugs that effect clotting → bleeding risk (esp GI)
  • E.g. Warfarin + SSRIs may increase anticoagulant effect and risk of bleeding; monitor INR and ↓ warfarin dose as needed.

B)

  • Increase risk with other drugs causing this effect.

C)

  • ↑ risk with other drugs causing this effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What type of impairment affects SNRI (metabolism)?

A

Dosage adjustments required in renal impairment (CrCl < 30ml/min)

Hepatic impairment - variable recommendations depending on the agent (duloxetine contraindicated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the adverse effects of SNRIs? how do they differ from SSRIs?

A

Similar adverse effects and precautions to SSRIs due to serotonergic actions

Suicide risk, serotonin syndrome, hyponatraemia, risk of bleeding, narrow angle glaucoma

> narrow angle glaucoma is a NA side effect

Cardiac effects

Use cautiously in patients with cardiac disease

Increases in BP reported with desvenlafaxine, duloxetine (infrequent) & venlafaxine

Control hypertension before starting desvenlafaxine or venlafaxine

Lipid effects

Elevations have occured with desvenlafaxine, use with caution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is agomelatine contraindicated?

A

Contraindicated in hepatic impairment or if aminotransferase concentration is > 3 X ULN.

> Caution if aminotransferases are already elevated or other risk factors for hepatic damage

> Additive hepatotoxic effects with other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When are TCAs used? What do they have a role in? When are they potentially lethal?

A

Used generally after unsuccessful trials of at least 2 first-line treatments

  • Have a role in severe melancholic depression
  • Potentially lethal in overdose!!! (cardiotoxicity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Precatuons of TCA?

A

suicide risk, CV disease, elderly, epilepsy (lowers seizure threshold like all antidepressants), hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What makes vortioxetine desirable?

A

Can be stopped without tapering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

For serotonin toxicity:

A) What are mild symptoms

B) What are the moderate symptoms

C) What are the severe symptoms

A

A)

  • Mydriasis, shivering, sweating, mild tachycardia

B)

  • disorientation, excitement, rigidity, tachycardia, hyperthermia (> 40) tremor, clonus, hyperreflexia

C)

  • Delirium, hypertension, hyperthermia, muscle rigidity, tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are te TWO treatment options for serotonin toxicity?

A

Cyproheptadine: 12mg single dose or 4 to 8mg tds

Chlorpromazine: 12.5 to 50mg slow IV infusion over 30 to 50min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to commence antidepressants?

A

Generally commence antidepressants with a low dose and gradually increase over 2 to 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is the full effect of antidepressants seen?

A

Full effects may take 4 to 8 weeks but improvement seen within 1 to 3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How long to continue drug treatment for after a single episode of major depression?

A

Continue drug treatment for 4 to 12 months after a single episode of major depression

> high risk of relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How to adjust treatment for depression medication?

A

Increase dose if full response not achieved (check adherence before adjusting therapy)

  • Up to maximum possible dose
  • Depending on side effects

Assess respone after 2 to 4 weeks

If a change is necessary can switch to an antidepressant from the same or a different class

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What to do for patients who fail to respond to antidepresasnt therapy? What are the key questions in assessing failure to respond to psychotropic drugs?

A

Is diagnosis correct

Has the patient been taking their medication regularly

Have possible underlying medical causes been identified and treated

Is the patient reacting adversely to a current medication

Have the drug dose and duration of administration been adequate

Have relevant psychosocial or personality factors been addressed

Have alcohol or other substance use problems been addressed n

Could an interacting drug be compromising the response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the FOUR options in treatment of resistant patients (refractory depression)?

A

Switching antidepressants

Augmentation strategies

Antidepressant polypharmacy

Electroconvulsive therapy (ECT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

For switching antidepressants;

A) What requires long washout periods?

B) TCAs and most SSRI (except fluoxetine) clear the drugs from the body within how long?

C) For other switches, what needs to be considered?

A

A)

  • Specified long washout periods are mandatory for irreversible MAOIs
  • Non selective irreversible MAOI and serotonin toxicity drug stays in body 2-3 weeks after it has been ceased –> severe HTN and serotonin toxicity

B)

around 5 days, the half life is around 20-30 hours

C)

Potential for withdrawal effects and need for tapering dose of agent being ceased

Half life of drug & continued effects → potential for interaction/toxicity during switch if the drug has a long half life

Clinical urgency for change/potential for relapse and exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What two antidepressants are most common for withdrawal effects? What is the general rule for discontinuing a drug?

A

Paroxetine and venlafaxine

Halve the dose every week until the daily dose is half of the lowest unit available, then stop after 1 week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What can rapid withdrawal of the more potently anticholinergic tricyclic antidepressants (TCAs) (eg amitriptyline) result in?

A

Cholinergic rebound (agitation, headache, sweating, gastrointestinal symptoms), parkinsonism and problems with balance.

> sailvation, lacrimation, urination, diarrhoea, GI distress, emesis SLUDGE = cholinergic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is Electro-convulsive therapy (ECT)?

A

Delivery of an electric current to induce a seizure for a therapeutic response (uni or bilateral)

  • Indicated for severe and unresponsive forms of depression
  • Response rate of 50 to 80%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How often is ECT given? What is done to prevent high relapse rate? What are the side effects?

A
  • Treatments given 3 times weekly or ↓ if cognitive impairment emerges
  • 6 to 14 treatments (up to 24 treatments)

Relapse rate high

  • Maintain recovery with pharmacotherapy (that has not been previously ineffective), lithium or mood stabiliser or combination

Side effects

  • Memory loss, muscle aches and pains, headaches, transient confusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How does exercise alleviate symptoms of depression?

A

↑ energy

Improve sleep

Positive distraction

Social support

↑ sense of control and self-esteem

May change levels of neurotransmitter

Trials have demonstrated regular exercise to be equally effective as antidepressants in mild to moderate depression

> decrease risk of developing depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Key Messages about depression

A
  • Depression may result in significant disability
  • Depression may be associated with a number of medications and medical conditions, in particular co-morbid psychiatric illnesses
  • Pharmacotherapy is indicated in moderate to severe MDD only
  • SSRIs are first line (in general) – need to consider what is best for the individual
  • Drug choice should be based on patient preference, past history of response, adverse effect profile, potential for toxicity in overdose, potential for drug interactions
  • Consider interactions due to CYP450 enzymes
  • Monitor for serotonin syndrome
  • Avoid withdrawal syndrome
  • Observe washout periods when switching antidepressants to reduce adverse effects
  • There is little evidence to support combinations of antidepressants, although the risk of adverse events is well documented
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Pyschosis from this card onwards …

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What to do if EPSE occurs?

A

ideally reduce antipsychotic dose or switch to alternative antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What treatment for the following EPSE?

A) Dystonias - stiffness, uncontrolled muscular spasms

B) Akathisia - inner restlessness, strong desire or compulsion to move

C) Parkinsonism - tremor and/or rigidity, mask- like face, shuffling gait, slow movements

D) Tardive Dyskinesia - involuntary abnormal movements of face, tongue, lips, hands or feet

A

A)

benzatropine (oral, inj), trihexyphenidyl (benzhexol)

B)

propranolol, clonazepam

C)

benzatropine, trihexyphenidyl

D)

Can be irreversible. Stop antipsychotic (preferred)

Treatment poor efficacy – tetrabenazine, Ginkgo biloba

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is first line treatment in schizophrenia?

A

2nd Generation Antipsychotics (SGAs)

More metabolic adverse effects

More expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Pharmacalogy of aripiprazole? What is it used to agument?

A

Is a dopamine system stabiliser (increased dopamine output when conc are low and decreased dopamine output when conc. are high)

  • Less sedation, weight gain and prolactin elevation
  • Good 1st choice antipsychotic
  • Doesn’t provide sedation if patient acutely unwell
  • May cause insomnia, akathisia and/or activation

> often used to augment other antipsychotics

> to reduce weight gain e.g. clozapine, olanzapine

> to reduce prolactin e.g. risperidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Pharmacology of brexpiprazole

A

Indicated only in schizophrenia

May have positive effects on mood

Well tolerated – little weight gain, prolactin elevation, akathisia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Pharmaclogy of lurasidone

A

Take with food to increase absorption

Low incidence weight gain, small rise in prolactin

Theorised to improve mood & be useful in bipolar

Reports of increased irritability/rage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Pharmacology of olanzapine

A

Sedating – may be beneficial in acute psychosis

WEIGHT GAIN +++

Metabolic syndrome major concern. For this reason falling out of favour as long term treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Pharmacology of paliperidone

A

Active metabolite of risperidone, similar adverse effects to risperidone

  • Swallow tablets whole –> Cannot be halved, crushed –> Empty tablet may appear in stools
  • always with food or always on an empty stomach
  • oral not commonly used but depot common
36
Q

Pharmacology of Quietiapine

A

Prone to abuse – watch for doctor shopping and picking up supply earlyn

More sedating at lower doses

To get antipsychotic effect, some patients require higher dose

37
Q

Pharmacology of Amisulpride? How does its MOA change from low to higher doses?

A

Indicated for treatment of schizophrenia

  • At low doses (50-300mg) it is more effective for negative symptoms
  • At higher doses (400-800mg) it is more effective for positive symptoms
  • Not metabolised in the liver; reduce dose in renal impairment
  • Dose-related EPSE & hyperprolactinemia
38
Q

Clozapine pharmacology? Why is it not 1st line?

A

The most effective antipsychotic

50% of non-responders will improve with clozapine

Particularly effective for negative symptoms

Not 1st line due to serious adverse effects

  • Agranulocytosis
  • Neutropenia
  • Cardiomyopathy
  • Myocarditis
  • Gastrointestinal Hypomotility – i.e. constipation = highest risk of mortality
39
Q

What is the condition of clozapine being used?

A

Must have trialled ≥2 antipsychotics prior to clozapine initiation

  • Not effective or not tolerated
  • At least 1 must be atypical antipsychotic
40
Q

What is done before treatment of clozapine can be done (monitoring)?

A

Monitoring systems record WCC and neutrophil count

  • Clopine Connect
  • Clozaril Patient Monitoring Service

Pre-treatment

  • FBP, CRP, troponin, ECG, echocardiogram ( pregnancy test)
  • Desired: LFTs, U&Es, lipids, weight, BSL/HbA1c, weight, waist circumferance,
41
Q

What ongoing monitoring for clozapine?

A

Ongoing monitoring. Medication only supplied until next blood test

  • FBP weekly for first 18 weeks
  • CRP, troponin weekly for 4 weeks

red range (stop immediately)

> WBC less than 3.0 x 109

> Neutrophils less than 1.5 x 109

amber range (continue therapy with twice weekly blood tests)

> WBC 3.0-3.5 x 109

> Neutrophils 1.5-2.0 x 109

green range

> WBC greater than 3.5 x 109

> Neutrophils greater than 2.0 x109

42
Q

Clozapine dosing/drug concentration

A

Slow dose titration to avoid/reduce dose dependent adverse effects

> Target drug concentration: 350-1000mcg/L

43
Q

For clozapine;

A) What to use to treat hypersalivation

B) What to use to treat GI hypomotility (constiaption)

A

A)

  • Atropine 1% eye drops sublingually
  • Hyoscine wafers
  • Ipratropium MDI sublingually
  • Moclobemide, metoclopramide

B)

  • Macrogol first line and BE AGGRESSIVE!
  • Docusate/senna first line for prophylaxis
44
Q

Why is medication used in acute agitation and arousal in patients with schizophrenia? What drugs to use?

A

Medication is used to calm/lightly sedate the patient and reduce the risk to self and/or others

  • Oral benzodiazepine (lorazepam, clonazepam, diazepam)
  • Oral antipsychotic (olanzapine, risperidone, quetiapine, haloperidol)
  • IM medication (lorazepam, olanazapine, ziprasidone, haloperidol, droperidol, midazolam, clonazepam)
  • IV med –> used in EDs, not used in psychiatric inpatient wards
45
Q

Which IM medication is preferred for acute agitiation?

A

IM lorazepam available under SAS – more predictable absorption & effect –> refrigerate, 3 months shelf life once out of fridge

46
Q

What is needed when benzodiazepines used IM/IV? When to use?

A

Have flumazenil available when benzodiazepines used IM/IV

Use if respiratory rate falls below 10/minute

47
Q

Pharmacology of Zuclopenthixol acetate. When are they used?

A

Used if other short-acting treatment options for acute agitation and arousal have been ineffective

> Not for long-term use. Duration of Tx cannot exceed 2 weeks, 400mg or 4 injections

48
Q

When is long acting (depot) antipsychotics used? How is it used?

A

Antipsychotic long-acting injections (LAIs) used where non-adherence to oral treatment is problematic, or patient prefers this formulation type

  • Deep intramuscular injection (gluteal or deltoid)
  • Medication slowly released into bloodstream, providing steady supply of medication.
  • LAIs do not ensure adherence: they assure awareness of adherence
  • Allow regular assessment of patient (due to regular injections)
49
Q

Advantages and disadvantages of LAI antipsychotics?

A

Advantages

Proven reduction in relapse

Improved adherence

Fewer hospitalisations

Less fluctuation in drug concentration

Regular contact with clinicians

Less risk of overdose

Avoids first pass metabolism

Disadvantages

Pain at injection site

Cannot be withdrawn quickly (E.g. side effects)

Patient loses control of treatment

Less dosing flexibility

Monitoring required (olanzapine)

50
Q

Pharmacology of aripiprazole LAI?

A

Gluteal or deltoid muscle

Oral test doses of aripiprazole

Oral antipsychotic required for 14 days after LAI is commenced

Indicated for treatment of:

Schizophrenia

BPAD – maintenance treatment (not PBS)

  • Favourable metabolic and prolactin-sparing effects
51
Q

All antipsychotics can reduce the seizure threshold/ What antipsychotics to avoid?

A

Clozapine, chlorpromazine – most epileptogenic

52
Q

What are the effects of smoking and smoking cessation with antipsychotics?

A

Cigarette smoking induces CYP1A2

  • Reduces plasma levels of drugs eg BZD, clozapine, olanzapine

Smoking cessation –> increased drug plasma levels –> consider dose reduction

53
Q

What to use for smoking cessation?

A

NRT has been used effectively for smoking cessation

  • Varenicline – Champix® - pschiatric adverse effects reported, but can be used with careful monitoring
  • Bupropion – Zyban® - not routinely used in psychiatric setting. Lowers seizure threshold
54
Q

What are effects of caffeine on antipsychotic drugs?

A

Caffeine can increase drug levels (clozapine and olanazapine)–> possibly due to competitive CYP1A2 inhibition

  • Patients with mental illness have been reported to drink large amounts of caffeinated drinks
55
Q

Why does NMS occur (Neuroleptic Malignant Syndrome)?

A

Thought to be due to a sudden over-blockade of dopaminergic function

> a very rare life-threatening syndrome that can occur with any antipsychotic medication

> antipsychotics that act on stronger dopamine receptors

56
Q

Symptoms of NMS (Neuroleptic Malignant Syndrome)? How to treat?

A

Characterised by fever, muscle stiffness, altered consciousness and problems with the autonomic nervous system

  • can be fatal if left untreated
  • treatment is symptomatic and antipsychotic should be ceased
57
Q

Concerns with elderly patients?

A
  • More susceptible to adverse effects including EPSE and TD
  • Lower starting doses of medications are used
  • There is some concern that olanzapine and risperidone may increase the chance of a stroke
  • Elderly patients more likely to have other illness or be on other medications
58
Q

How to deal with side effects

A) Akathisia

B) Sedation

C) nausea

D) constipation

weight gain: combination of good diet and exercise, prevention better than treatment

> metformin and augmentation with aripiprazole can reduce weight gain

A

A)

stretching & exercise

B)

take medication at night (if once daily dose) e.g. clozapine small dose in morning and large dose at night

C)

take with or after food

D)

balanced diet, increase fibre and fluid intake

Coloxyl & Senna, Movicol

59
Q

Dementia after this card…

A
60
Q

What is dementia defined as?

A

Distinguished from lifelong intellectual disability and single learning disorders as dementia develops during life, and involves alteration in two or more cognitive functions

61
Q

What is used to treat primary symptoms such as memory loss in alzheimers?

A

Anticholinesterases

NMDA antagonists

62
Q

What is used to treat seconday symptoms such as depression and hallucinations in alzheimers?

A

Antipsychotics and Sedatives

63
Q

How do anticholinesterases work?

> donepezil, galantamine, rivastigmine

A

Accumulation of AB (beta amyoloid) peptide results in destruction of cholinergic neurones and a fall in ACh concentration

> neurotransmitter essential for learning and memory

  • Cholinesterase inhibitors (CIs) inhibit breakdown of ACh to increase concentrations in synaptic cleft

> enhances cholinergic function and reduces loss of cholinergic neurotransmitter activity

64
Q

All three CIs seem to have similar efficacy, they dont alter pathology of AD, so how do they work?

> donepezil may be slightly more effective

A

temporarily delay progression and improve symptoms according to subjective measurements or cognitive assessment tools (e.g. MMSE)

> not everyone responds to treatment

65
Q

What are the adverse effects (CIR) associated with CI? Which one has most GI adverse effects?

A

Adverse effects occur frequently with all three agents

Better tolerated if slowly titrated to target dose –> increase every four to six weeks

  • full dose oral rivastigmine may have more GI adverse effects than donepezil or galantamine

Common​

nausea, vomiting, diarrhoea, anorexia, abdominal pain, dyspepsia, headache, insomnia, vivid dreams, depression, fatigue, drowsiness, dizziness, tremor, weight loss, muscle cramps, urinary incontinence, increased sweating, hypertension, syncope

Infrequent or rare

bradycardia, heart block, seizure, agitation, hallucination, confusion, GI haemorrhage

66
Q

Which non-alzheimer dementia should CI be used in?

A

There is good evidence to support treatment with rivastigmine and donepezil in in dementia with Lewy bodies and Parkinson’s disease dementia

67
Q

Properties of memantine? MOA, is it effective? Who is it used for?

A

Thought to protect against elevated levels of glutamate

  • NMDA antagonist
  • but memantine does not stop AD progression

Generally reserved for severe dementia or those intolerant to CIs

68
Q

Factors to consider in relation to continuing CI/ memantine use are the level of? How is this demonstrated?

A

Clinically meaningful response to treatment may be demonstrated by the person’s:

  • quality of life
  • cognitive function
  • behavioural symptoms

> The presence of adverse effects that impact on quality of life and clinical symptoms should prompt a review of the ongoing need for the agent

> People who demonstrate ongoing, meaningful clinical benefit (functionally and/ or cognitively stable) should continue on the medication with ongoing monitoring for continued benefit or the development of any adverse effects

69
Q

What are behavioural symptoms associated with dementia?

A

physical aggression, screaming, restlessness, agitation, wandering, culturally inappropriate behaviours, sexual disinhibition, hoarding, cursing and shadowing.

70
Q

What are psychological symptoms associated with dementia?

A

anxiety, depressive mood, hallucinations and delusions

71
Q

1st line treatment for psychological and behavioural symptoms?

A

Non-pharmacological approaches first line for responsive behaviours because of a favourable balance of benefits and harms

> Drug therapy should not be first-line for patients with responsive behaviours

72
Q

Who are antipsychotics reserved for? What symptoms are they ineffective for? Why risk of AE so high?

A

Reserve for residents with distressing agitation, aggression, delusions or psychoses

  • Ineffective in treating wandering or disinhibition

AE: increased risk of mortality, stroke and extrapyramidal symptoms

73
Q

what antipsychotics to use for hallucinations, delusions or seriously disturbed behaviour?

A

Risperidone or olanazapine

74
Q

AE of antipsychotics?

A

AEs frequent as antipsychotics affect multiple neurotransmitter receptor types and subtype

Common: sedation, anxiety, agitation, EPSE, orthostatic hypotension, tachycardia, sexual adverse effects, weight gain, hyperprolactinaemia (may result in galactorrhoea and/ or gynaecomastia)

> EPSE and orthostatic HTN with risperidone

> Olanzapine and some older agents: blurred vision, mydriasis, constipation, nausea, dry mouth, urinary retention

> Avoid typical antipsychotics in residents with Lewy bodies dementia or Parkinson’s disease –> worsen movement disorders

75
Q

When is extrapyramidal side effects highest? What drugs to avoid?

A

Incidence dose-related

> highest with haloperidol, lowest with some of the newer agents

  • Reduce antipsychotic dose to avoid recurrent EPSE when possible
  • Avoid anticholinergic drugs (e.g. benztropine)

> may add to anticholinergic effects and worsen tardive dyskinesia and cognition

76
Q

What are some extrapyramidal side effects that may be mistaken for responsive behaviours when using antipsychotics?

A

Dystonias

  • Torticollis, carpopedal spasm, trismus, perioral spasm, oculogyric crisis, laryngeal spasm and opisthotonos

Akathisia

  • Feeling of motor restlessness; usually occurs 2–3 days (up to several weeks) after starting treatment and may subside spontaneously
  • May present as agitation secondary to psychosis

Parkinsonism

  • Tremor, rigidity or bradykinesia; usually develops after weeks or months

Tardive dyskinesia

  • Involuntary movements of the face, mouth or tongue, and sometimes head and neck, trunk or limbs
77
Q

Clozapine, olanzapine and quetiapine, associated with?

A

increased blood glucose, weight gain and dyslipidaemia

  • clozapine and olanzapine associated with increased risk of type 2 diabetes
78
Q

Increased death rate in which antipsychotics?

Increased risk of fatal and non-fatal strokes and TIAs in which antispychotics?

A

Increased death rate noted in placebo-controlled trials of aripiprazole, olanzapine, quetiapine and risperidone in dementia patients (due to CVD events or infections)

Olanzapine and risperidone associated with increased risk of fatal and non-fatal strokes and TIAs

> use for lowest possible dose and shortest amount of time

79
Q

Risk of CVA increased for patients being treated with _________ for vascular or mixed dementia, compared with those taking it for Alzheimer’s dementia

A

risperidone

  • TGA approval for use in responsive behaviour is limited to treatment (up to 12 weeks) of moderate to severe dementia only of the Alzheimer type
80
Q

Points for withdrawal of antipsychotics?

A
  • Most responsive behaviours tend to be transient exacerbations
  • Many will resolve naturally as dementia progresses
  • Regular monitoring and dose reduction/ withdrawal attempts should be undertaken to minimise exposure to antipsychotic use
  • E.g. halve the dose every two weeks until the lowest possible dose is achieved, treat for a further two weeks then cease
  • Antipsychotic treatment can always be reintroduced if required
81
Q

How do BZDs work? what ar they used for? Which one to use?

A

Potentiate inhibitory effects of GABA throughout CNS –> results in Potentiate inhibitory effects of GABA in the CNS –> anxiolytic, sedative, hypnotic, muscle relaxant and antiepileptic effects

  • Short term use may assist some behavioural and psychological symptoms of dementia (BPSD), especially insomnia, anxiety, irritability and tension

> also use as premedication for anxiety-inducing events

> To relieve symptoms of severe anxiety and agitation, use: oxazepam 7.5 mg orally, 1 to 3 times daily

82
Q

AE of BZD? What happens if used for more than 2 weeks?

A

Worsen cognitive impairment, impair gait and increase the risk of falls

> Particularly long-acting agents, such as nitrazepam and diazepam

> Associated with increased risk of hip fracture among older people by >50%

  • Use >2 weeks associated with tolerance to sedative effect
  • Longer term use results in dependence
  • Cognition and gait effects maintained
83
Q

_____ ______ are often amongst the most difficult symptoms of dementia to adequately support. What medications have been used to try to alleviate these symptoms?

A

Responsive behaviours

  • anticonvusaltant mood stabilisers, antidepressants, clonidine, cannabis, dextropropoxyphene

> citalopram for agitation has been shown to be effective

84
Q

What is the most effective strategy for this: responsive behaviours are often amongst the most difficult symptoms of dementia to adequately support

A

Identifying and addressing the unmet need/ sources of responsive behaviour is typically the most effective strategy

> Specialist services are available for these situations –> DBMAS, SBRT, OAMHS

85
Q

Summary

A
  • Development of disease- modifying treatments has been unsuccessful
  • Current pharmacological treatments for dementia are generally of limited effectiveness

> This includes medications for both the cognitive and behavioural/ psychological aspects of the condition

  • Any medication used in managing dementia symptoms requires regular review for ongoing effectiveness and adverse effects

> Particularly antipsychotics and other sedatives

Bal (PPP1) (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions